Product Design and Prototype Center Opens at Swanson School of Engineering

Read More

HiberSense Wins $10K in AUTM Venture Challenge

Media Release HiberSense Wins $10K in AUTM Venture Challenge AUSTIN, Texas - February 14, 2019 — HiberSense, Inc., a start-up from the University of Pittsburgh Innovation Institute, has won the $10,000 top prize in AUTM’s Pitch and Play business plan competition at the Association’s 2019 Annual Meeting in Austin, Texas.…

Read More

A New Wrinkle on Vascular Implants

  February 14, 2019   From Engineering Student to Startup CEO: Research Project Sends Pitt Undergrad's Life in New Direction Joe Pugar has always been fascinated with the elegant structures, systems and mechanics of nature.  From the tensile strength of spider silk to the energy conversion ability of photosynthesis, he…

Read More

Center for Medical Innovation Awards $105,000 to 5 Research Groups

Read More

University of Pittsburgh Announces Patents Issued in January 2019

February 11, 2019 The University of Pittsburgh announced that Pitt innovators were issued 17 U.S. patents in January 2019. Featured Patent: U.S. 10,167,519 "Fusion Gene Associated with Progressive Prostate Cancer" Jianhua Luo, professor in the Department of Pathology, and colleagues have developed methods and compositions for determining whether a person…

Read More

University of Pittsburgh Announces Patents Issued in December 2018

January 10, 2019 The University of Pittsburgh announced that Pitt innovators were issued six patents in December 2018. Featured Patent: U.S. 10,160,974 "Engineered Cytokne and Chemokine-Expressing Candida Albicans Strains and Methods of Use" A team led by Sarah Gaffen, professor of rheumatology, has genetically modified strains of Candida albicans (C.…

Read More

University of Pittsburgh Announces Patents Issued in November 2018

December 7, 2018 The University of Pittsburgh announced that Pitt innovators were issued seven patents in November 2018. Featured Patent: U.S. 10,137,236 "Self-Regulating Device for Modulating Inflammation" The innovators, led by Yoram Vodovotz, Professor of Surgery, Immunology, Computational and Systems Biology and Bioengineering, have conceived a medical device that employs…

Read More

Pitt Innovators Recognized at the 13th Annual Celebration of Innovation

Who needs Amazon? Pittsburgh's transformation into a serious player in the information age is accelerating from within.  That was the message at the University of Pittsburgh Innovation Institute's 13th Annual Celebration of Innovation at Alumni Hall Monday evening. The event celebrated Pitt innovators, who set cords for the number…

Read More

Regenerative Medicine Pioneer Named 2018 Marlin Mickle Outstanding Innovator

NOVEMBER 28, 2018 Stephen Badylak Seeks to Grow His Lab's Impact Through New Startup Company Stephen Badylak’s unorthodox path to medicine always sought to combine the benchtop and the bedside. After treating patients for 16 years, he moved exclusively to the lab when he joined the University of Pittsburgh in…

Read More

Pitt and CMU Join Forces to Promote Entrepreneurship

  View this post on Instagram   A post shared by Pitt Innovation Institute (@pittinnovates) on Nov 13, 2018 at 11:03am PST Perhaps it was coincidence that in the same week that Pittsburgh received the news that it would not be the host for Amazon Inc.’s second (or third) headquarters,…

Read More

University of Pittsburgh Announces Patents Issued in October 2018

November 15, 2018 The University of Pittsburgh announced that Pitt innovators were issued eight patents in October 2018. Featured Patent: U.S. 10,085,721 "Contrast Assisted Intravascular Ultrasound Imaging" This technology details development of a novel intravascular ultrasound (IVUS) imaging method and apparatus for molecular imaging and characterization of cardiovascular diseases for…

Read More

Innovations in Cancer Treatment and Predictive Modeling Capture 2018 Wells and Kuzneski Competitions

A year ago the Food and Drug Administration (FDA) approved the first gene therapy in the U.S. The drug, Kymyriah, from pharmaceutical company Novartis, is a type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy. It was approved to treat acute lymphoblastic leukemia, a cancer of the blood.…

Read More